Market Place
Sourcing Support
VIDEO: AXIM CEO Presents at Benzinga Virtual Healthcare Summit 2024
27 Mar 2024 //
GLOBENEWSWIRE
AXIM® Biotechnologies™ Tear Based Testing Platform Continues to Gain Traction
20 Feb 2024 //
GLOBENEWSWIRE
AXIM Partners With Manufacturer Auer Precision to Scale Assay Production
20 Dec 2023 //
GLOBENEWSWIRE
AXIM® Biotechnologies Develops First Diagnostic Test for Parkinson’s Disease
12 Sep 2023 //
BUSINESSWIRE
AXIM® Bio Receives Notice of U.S. Patent Allowance for Three Separate Patents
01 Aug 2023 //
BUSINESSWIRE
AXIM® Starts Shipping Revenue Generating IgE Diagnostic Validation Assays
12 Jul 2023 //
GLOBENEWSWIRE
AXIM Biotechnologies Announces Over 40 Initial Clinic Commitments
24 May 2023 //
GLOBENEWSWIRE
AXIM Biotechnologies Appoints Kurt Phinney as Chief Operating Officer
23 May 2023 //
GLOBENEWSWIRE
AXIM Commences Manufacturing of FDA-Cleared Proprietary Ocular Diagnostic Assays
11 Apr 2023 //
GLOBENEWSWIRE
AXIM Biotechnologies Files Provisional Patent on Novel Methodology
14 Mar 2023 //
GLOBENEWSWIRE
AXIM Biotechnologies Files Patent on Fentanyl Neutralizing Antibody Test
17 Jan 2023 //
GLOBENEWSWIRE
AXIM Biotech Develops Dual IgE/MMP-9 Rapid Ophthalmological Diagnostic Test
13 Dec 2022 //
GLOBENEWSWIRE
AXIM Biotechnologies Commercial Partner Verséa Ophthalmics Highlights Benefits
06 Dec 2022 //
GLOBENEWSWIRE
AXIM® Biotechnologies Receives Initial Order for Diagnostic Solutions
04 Oct 2022 //
GLOBENEWSWIRE
AXIM® Biotechnologies Point-of-Care Diagnostic Test Platform Sales Commence
29 Sep 2022 //
GLOBENEWSWIRE
AXIM® Biotechnologies Signs Exclusive Global Commercialization Verséa™
19 Sep 2022 //
GLOBENEWSWIRE
AXIM Biotech Enhances IgE Testing Capabilities; Responds to Global Warming
26 Jul 2022 //
GLOBENEWSWIRE
AXIM Bio Publishes Study on Neutralizing Ab Levels of Poor Vaccine Responders
12 Jul 2022 //
GLOBENEWSWIRE
AXIM Biotechnologies Develops Novel Tear Sample Collector System
10 May 2022 //
GLOBENEWSWIRE
AXIM Biotechnologies CEO Issues Letter to Shareholders
19 Apr 2022 //
GLOBENEWSWIRE
AXIM Biotech Announces New Milestones in Preparation of DED Diagnostics Launch
15 Feb 2022 //
GLOBENEWSWIRE
CDC Publishes AXIM Biotechnologies-Sponsored Study on COVID-19 Neutralizing Ab
21 Dec 2021 //
GLOBENEWSWIRE
AXIM Biotechnologies Partners with Arizona State University to Determine
16 Nov 2021 //
GLOBENEWSWIRE
AXIM Biotechnologies’ Development of Rapid Test for COVID-19 Antibodies
09 Nov 2021 //
GLOBENEWSWIRE
Empowered Diagnostics files EUA for its Rapid COVID-19 Neutralizing Ab Test
30 Aug 2021 //
GLOBENEWSWIRE
AXIM® Biotechnologies Completes Pre-Clinical Drug Studies on SPX-1009
26 May 2021 //
GLOBENEWSWIRE
AXIM® Receives Notice of USPTO for QSOX1
22 Sep 2020 //
GLOBENEWSWIRE
AXIM® Biotechnologies Begins Pre-Clinical Pharmacokinetic Animal Drug SPX-1009
01 Jun 2020 //
GLOBENEWSWIRE
AXIM`s Acquiree Sapphire Biotech,Signs Sponsored Research Agreement
10 Feb 2020 //
BIOSPACE
AXIM`s Acquiree Sapphire Biotech,Signs Sponsored Research Agreement
10 Feb 2020 //
BIOSPACE
AXIM® Biotechnologies Acquiree Sapphire Biotech, Inc.
23 Jan 2020 //
GLOBE NEWSWIRE
ANI Pharmaceuticals Announces Acquisition of Amerigen Pharmaceuticals, Ltd.
09 Jan 2020 //
BIO SPACE
